PRMT1 promotes the tumor suppressor function of p14 <sup>ARF</sup> and is indicative for pancreatic cancer prognosis
2021 · The EMBO Journal · 40 citations
https://doi.org/10.15252/embj.2020106777
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
379
Citations
7
h-index
6
i10-index
Marion Meixner is an academic researcher from Philipps University of Marburg. The author has contributed to research in topics: Epigenetics and DNA Methylation & Cancer-related gene regulation & Sphingolipid Metabolism and Signaling. The author has an h-index of 7, co-authored 12 publications.
ORCID: 0000-0002-6882-5426https://doi.org/10.15252/embj.2020106777
https://doi.org/10.1007/s13402-024-01001-0
Click to start Chat